Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from Insulin to Metformin & Saxagliptin in T2DM
NCT01206647Phase 4Unknown
- Sponsor
- ikfe CRO
- Start
- Feb 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by ikfe CRO. Status: unknown.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01206647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01206647.